This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Stock Moves -0.86%: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $147.38, marking a -0.86% move from the previous day.
3M (MMM) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does 3M (MMM) have what it takes? Let's find out.
3M (MMM) Stock Moves -0.42%: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $148.90 in the latest trading session, marking a -0.42% move from the prior day.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $149.53, moving -0.11% from the previous trading session.
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $152.08, moving +1.75% from the previous trading session.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $149.47 in the latest trading session, marking a -0.66% move from the prior day.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $149.94, marking a +0.92% move from the previous day.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $148.58, moving +0.18% from the previous trading session.
Honeywell's (HON) Forge Solution Selected by Lincoln Harris
by Zacks Equity Research
Honeywell's (HON) Forge solution will enable Lincoln Harris to detect building maintenance issues and improve occupants' experience.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $143.48, moving +1.79% from the previous trading session.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $145.40 in the latest trading session, marking a +1.48% move from the prior day.
3M (MMM) Sells Floor Products Arm, Revamps Business Portfolio
by Zacks Equity Research
3M's (MMM) sale of the floor products business unit will enable it to better focus on and efficiently direct resources to its core businesses.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $147.22 in the latest trading session, marking a +1.71% move from the prior day.
Why Is 3M (MMM) Down 14.7% Since Last Earnings Report?
by Zacks Equity Research
3M (MMM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3M (MMM) '22 Earnings to Grow on Robust Sales Amid Supply Woes
by Zacks Equity Research
3M (MMM) communicates that its earnings performance in 2022 will reflect gains from sales growth, lower pandemic-induced demand for respirators, cost inflation and effective pricing.
How Are Industrial ETFs Reacting to Mixed Q4 Earnings?
by Sweta Jaiswal, FRM
The industrial sector is expected to rebound from the coronavirus-led slump as the U.S. economy is expected to keep recovering in the rest of 2022.
3M (MMM) Announces 0.7% Hike in Quarterly Dividend Rate
by Zacks Equity Research
3M (MMM) board hikes the quarterly dividend rate by 0.7%. The move is in sync with the company's shareholder-friendly policies.
Top Research Reports for Meta Platforms, UnitedHealth & salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (FB), UnitedHealth Group Incorporated (UNH), and salesforce.com, inc. (CRM).
Company News for Jan 26, 2022
by Zacks Equity Research
Companies in The News Are: JNJ,LMT,ERIC,MMM
3M's (MMM) Earnings and Revenues Surpass Estimates in Q4
by Zacks Equity Research
3M's (MMM) fourth-quarter 2021 net sales increase 0.3% year over year on account of impressive performance across its Health Care and Consumer segments.
3M (MMM) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 13.79% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Did Stock Markets Touch Bottom Today?
by Mark Vickery
We saw the indexes come roaring back, particularly in the last hour of regular trading, which surged each major index into the green.
S&P 500 Enters Correction Territory As Investors De-Risk Ahead of Fed Meeting & Big Tech Earnings
by Daniel Laboe
Bears have taken market control but the Fed's policy decision coupled with big tech earnings could reverse this negative narrative
Conglomerates Q4 Earnings Worth a Watch This Week: GE, DHR, MMM
by Payal Jalan
Conglomerate's Q4 results are likely to reflect gains from better economic and manufacturing activities, supply-chain woes, and cost inflation. Earnings releases by GE, DHR and MMM are worth a look.
Danaher (DHR) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Danaher (DHR) Q4 results to reflect gains from better-than-expected segmental top-line performances, mainly Diagnostics and Life Sciences. Cost inflation is likely to have been affecting margins.